BrainStorm Cell Therapeutics
BCLI
#9868
Rank
NZ$10.96 M
Marketcap
$2.06
Share price
7.08%
Change (1 day)
590.79%
Change (1 year)

Earnings for BrainStorm Cell Therapeutics (BCLI)

Earnings in 2024 (TTM): -NZ$20.71 Million

According to BrainStorm Cell Therapeutics's latest financial reports the company's current earnings are N/A. In 2022 the company made an earning of -NZ$41.39 Million, an increase over its 2021 earnings that were of -NZ$41.69 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BrainStorm Cell Therapeutics from 2003 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) -NZ$20.71 Million
2022 -NZ$41.39 Million-0.74%
2021 -NZ$41.69 Million-23.12%
2020 -NZ$54.23 Million36.8%
2019 -NZ$39.64 Million66.71%
2018 -NZ$23.78 Million181.66%
2017 -NZ$8.45 Million-0.6%
2016 -NZ$8.5 Million-41.31%
2015 -NZ$14.47 Million-8.22%
2014 -NZ$15.77 Million89.74%
2013 -NZ$8.31 Million42.27%
2012 -NZ$5.84 Million-12.45%
2011 -NZ$6.67 Million63.04%
2010 -NZ$4.1 Million35.52%
2009 -NZ$3.02 Million-48.99%
2008 -NZ$5.92 Million-44.39%
2007 -NZ$10.65 Million
2005 -NZ$5.52 Million-91.44%
2004 -NZ$64.4 Million94007.62%
2003 -NZ$0.07 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
NZ$2.62 B-12,406.95%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$0.93 Billion 4,263.28%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$1.35 Billion 6,226.13%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$2.23 B-10,613.72%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$0.19 Billion 758.93%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$0.44 Billion 1,944.40%๐Ÿ‡บ๐Ÿ‡ธ USA